Kraig Biocraft Deploys 700,000 Spider Silk Hybrids, Hits Key Production Milestone
summarizeSummary
Kraig Biocraft Laboratories announced the successful deployment of over 700,000 BAM-1 Alpha production hybrids, representing a significant portion of its 1,000,000 egg inventory, which are now actively producing spider silk. This achievement marks a key milestone in the company's aggressive plan to scale production to metric ton levels, following its February outline for dramatic increases in output. This operational progress demonstrates successful execution of its strategy and validates the BAM-1 Alpha platform, building on the recent expansion of R&D capacity reported on March 23rd. For a small biotechnology company, hitting such concrete production milestones is critical for de-risking its technology and paving the way for future commercialization. Investors will be watching for continued updates on production volumes and potential commercial partnerships.
At the time of this announcement, KBLB was trading at $0.12 on OTC in the Life Sciences sector, with a market capitalization of approximately $128.8M. The 52-week trading range was $0.07 to $0.15. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.